NCT00767936|Terminated
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma
Loading search results
Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma
Sponsor study identifier
Secondary identifiers
OTHER · Stanford University Alternate IRB Approval Number
OTHER · Stanford University
observational
135
1 country
1
Study Start
March 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2013
Actual (reported)Study Completion
September 2013
Actual (reported)Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2013
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2008
Date type not reportedThis date has not been verified as actual or estimated.
October 3, 2008
Actual (reported)October 7, 2008
Actual (reported)March 2013
Actual (reported)September 2013
Actual (reported)identify mutations in the hepatitis B virus genome that predisposes these high risk individuals to the development of liver cancer
We will be using blood specimens collected through another protocol
one time
liver cancer and non-cancer liver conditions
Contact the study team to confirm eligibility.
Stanford University School of Medicine
Stanford, California, 94305, United States
blood
Samuel So
Stanford University
135 participants (actual enrollment reported by the registry).
First Submitted
October 3, 2008
First Posted
October 7, 2008
Study Start
March 2008
Date type not reportedThis date has not been verified as actual or estimated.
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Primary Completion
March 2013
Actual (reported)Study Completion
September 2013
Actual (reported)Last Updated
June 29, 2016
Record last verified: 2016-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: